During the past decade, Carilion Infectious Disease conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carilion Infectious Disease" #1 collaborator was "Department of Health and Human Services" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Carilion Infectious Disease" are "Cough" (1 trials), "Fever" (1 trials), "Headache" (1 trials), "Influenza" (1 trials) and "Nasal Congestion" (1 trials). Many other conditions were trialed in "Carilion Infectious Disease" in a lesser frequency.

Most popular intervention types in "Carilion Infectious Disease" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "40 mg Laninamivir Octanoate" (1 trials), "80 mg Laninamivir Octanoate" (1 trials), "Peramivir+SOC" (1 trials), "Placebo" (1 trials) and "Placebo+SOC" (1 trials). Other intervention names were less common.

The vast majority of trials in "Carilion Infectious Disease" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Carilion Infectious Disease". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Carilion Infectious Disease, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Carilion Infectious Disease, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".